用分子方法鉴定伯纳蒂克希菌感染，美国，2006-2023

IF 6.6 2区医学 Q1 IMMUNOLOGY Emerging Infectious Diseases Pub Date : 2025-03-12 DOI:10.3201/eid3104.241214

Caroline K. Maki, Thao T. Truong, Johanna S. Salzer, Nicolette Bestul, Brad T. Cookson, Gilbert J. Kersh, Stephen J. Salipante, Joshua A. Lieberman, David W. McCormick

{"title":"用分子方法鉴定伯纳蒂克希菌感染，美国，2006-2023","authors":"Caroline K. Maki, Thao T. Truong, Johanna S. Salzer, Nicolette Bestul, Brad T. Cookson, Gilbert J. Kersh, Stephen J. Salipante, Joshua A. Lieberman, David W. McCormick","doi":"10.3201/eid3104.241214","DOIUrl":null,"url":null,"abstract":"We identified 34 patients with Coxiella burnetii infection using PCR; 31 (86%) cases were diagnosed from cardiac specimens. Nearly half (15/31, 48%) of those cases were not reported to any channel of national disease surveillance, indicating substantial underreporting for diseases identified using molecular methods at noncommercial laboratories.","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":"32 1","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Coxiella burnetii Infections Identified by Molecular Methods, United States, 2006–2023\",\"authors\":\"Caroline K. Maki, Thao T. Truong, Johanna S. Salzer, Nicolette Bestul, Brad T. Cookson, Gilbert J. Kersh, Stephen J. Salipante, Joshua A. Lieberman, David W. McCormick\",\"doi\":\"10.3201/eid3104.241214\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We identified 34 patients with Coxiella burnetii infection using PCR; 31 (86%) cases were diagnosed from cardiac specimens. Nearly half (15/31, 48%) of those cases were not reported to any channel of national disease surveillance, indicating substantial underreporting for diseases identified using molecular methods at noncommercial laboratories.\",\"PeriodicalId\":11595,\"journal\":{\"name\":\"Emerging Infectious Diseases\",\"volume\":\"32 1\",\"pages\":\"\"},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2025-03-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Emerging Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3201/eid3104.241214\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3104.241214","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

我们用PCR方法鉴定了34例伯纳蒂克希菌感染患者；31例（86%）通过心脏标本确诊。这些病例中有近一半（15/ 31,48 %）没有向任何国家疾病监测渠道报告，这表明在非商业实验室使用分子方法确定的疾病有大量漏报。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Coxiella burnetii Infections Identified by Molecular Methods, United States, 2006–2023

We identified 34 patients with Coxiella burnetii infection using PCR; 31 (86%) cases were diagnosed from cardiac specimens. Nearly half (15/31, 48%) of those cases were not reported to any channel of national disease surveillance, indicating substantial underreporting for diseases identified using molecular methods at noncommercial laboratories.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.